DHA-clozapine Clinical data Trade names Clozaprexin Pregnancy cat. ? Legal status ? Identifiers CAS number ATC code ? Synonyms Docosahexaenoyl clozapine Chemical data Formula C40H49ClN4O Mol. mass 637.30 g/mol
DHA-clozapine (trade name Clozaprexin) is an atypical antipsychotic that has been developed by Protarga. The drug has been created by the association of the fatty acid docosahexaenoic acid (DHA) with clozapine. The advantages of this drug are that until the DHA and clozapine are separated, the drug is inactive; once it penetrates the blood brain barrier, the DHA and clozapine are freed from each other slowly by enzymatic activity and therefore more clozapine is liberated where it is needed, rendering the drug much more potent, actively longer in duration, and therefore requiring a much lower dosage, which results in fewer side effects. The drug is not yet available.
- ^ Preclinical Data on Novel Antipsychotic Agent, Harvard Medical School Investigators Report
- ^ Baldessarini, R.; Campbell, A.; Webb, N. L.; Swindell, C. S.; Flood, J. G.; Shashoua, V. E.; Kula, N. S.; Hemamalini, S. et al. (2001). "Fatty Acid Derivatives of Clozapine Prolonged Antidopaminergic Activity of Docosahexaenoylclozapine in the Rat". Neuropsychopharmacology 24 (1): 55–65. doi:10.1016/S0893-133X(00)00173-1. PMID 11106876.
This drug article relating to the nervous system is a stub. You can help Wikipedia by expanding it.